REG - Oxford Nanopore Tech - Result of AGM

Oxford Nanopore TechnologiesAnnouncement

04/06/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250604:nRSD4368La&default-theme=true

RNS Number : 4368L  Oxford Nanopore Technologies plc  04 June 2025

04 June 2025

Oxford Nanopore Technologies plc

(the "Company")

Results of Annual General Meeting

 

The Annual General Meeting of the Company was held earlier today. All
resolutions, as set out in the Company's Notice of Annual General Meeting
dated 30 April 2025, were passed by the appropriate majority on a
poll. Details of the poll results are set out below.

 

Oxford Nanopore Technologies plc Annual General Meeting Poll Results:

 

 

 No.    RESOLUTION                                                                     VOTES        %       VOTES        %      VOTES        % of ISC VOTED  VOTES

FOR
AGAINST
TOTAL
WITHHELD
 1.     To receive and consider the Directors' report, the Audited Statement of        642,469,240  100.00  25,908       0.00   642,495,148  66.86%          6,876,840
        Accounts and Auditor's Report of the Company for the financial year ended 31
        December 2024
 2.     To receive and approve the Directors' Remuneration Report for the year ended   640,466,861  99.66   2,175,681    0.34   642,642,542  66.87%          6,729,446
        31 December 2024
 3.     To receive and approve the Directors' Remuneration Policy                      640,487,359  99.58   2,691,923    0.42   643,179,282  66.93%          6,192,706
 4.     To elect Dr Daniel Mahony as a director of the Company                         636,940,143  99.98   118,587      0.02   637,058,730  66.29%          12,313,258
 5.     To re-elect Dr Sarah Fortune as a director of the Company                      633,477,558  98.52   9,519,311    1.48   642,996,869  66.91%          6,375,119
 6.     To re-elect Adrian Hennah as a director of the Company                         630,186,574  98.01   12,805,716   1.99   642,992,290  66.91%          6,379,698
 7.     To re-elect Nicholas Keher as a director of the Company                        637,060,716  99.98   141,931      0.02   637,202,647  66.31%          12,169,341
 8.     To re-elect John O'Higgins as a director of the Company                        637,006,927  99.08   5,932,235    0.92   642,939,162  66.90%          6,432,826
 9.     To re-elect Dr Heather Preston as a director of the Company                    633,553,236  98.52   9,521,168    1.48   643,074,404  66.92%          6,297,584
 10.    To re-elect Katherine (Kate) Priestman as a director of the Company            630,088,976  97.98   12,990,968   2.02   643,079,944  66.92%          6,292,044
 11.    To re-elect Dr Gurdial (Gordon) Sanghera as a director of the Company          636,100,503  98.90   7,082,497    1.10   643,183,000  66.93%          6,188,988
 12.    To re-elect Duncan Tatton-Brown as a director of the Company                   423,014,842  65.83   219,531,387  34.17  642,546,229  66.86%          6,825,759
 13.    To appoint Deloitte LLP as auditors of the Company                             638,373,565  99.25   4,818,777    0.75   643,192,342  66.93%          6,179,646
 14.    To authorise the Audit & Risk Committee to determine the remuneration of       643,005,482  99.97   195,114      0.03   643,200,596  66.93%          6,171,392
        the auditors
 15.    To authorise the board of directors to allot shares                            636,523,885  98.96   6,672,536    1.04   643,196,421  66.93%          6,175,567
 16.    To disapply pre-emption rights*                                                638,525,364  99.30   4,490,000    0.70   643,015,364  66.91%          6,356,624
 17.    To further disapply pre-emption rights*                                        630,426,434  98.04   12,581,864   1.96   643,008,298  66.91%          6,363,690
 18.    To authorise the Company to make market purchases*                             643,119,265  99.98   113,576      0.02   643,232,841  66.93%          6,139,147
 19.    To authorise the Company to hold any general meeting (other than an Annual     641,615,906  99.75   1,619,955    0.25   643,235,861  66.93%          6,136,127
        General Meeting) on not less than 14 clear days' notice*
 20.    To authorise UK political expenditure not exceeding £100,000                   642,333,582  99.90   660,073      0.10   642,993,655  66.91%          6,378,333
 21.    To authorise the proposed amendment to the LTIP rules                          641,683,377  99.80   1,285,980    0.20   642,969,357  66.91%          6,402,631

 

* Special Resolution

 

NOTES:

 

1.   Votes "For" and "Against" are expressed as a percentage of votes
received.

 

2.   The total number of ordinary shares in issue and eligible to be voted
on at the AGM was 960,995,120.

 

3.   A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against" any
resolution nor in the calculation of the proportion of "Total issued share
capital voted" for any resolution.

 

4.   The Board appreciates the support shown by shareholders for the
resolutions at today's AGM. Whilst all resolutions were passed, the Board
acknowledges the outcome of the vote on Resolution 12, for which over 20% of
votes cast were against. The Board will continue to engage with shareholders
in constructive and open dialogue around the reasons for the votes against
this Resolution and will provide an update to shareholders within six months
of today's meeting.

 

In accordance with Listing Rule 9.6.2, a copy of the resolutions will shortly
be submitted to the National Storage Mechanism and will be available for
inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

A copy of the poll results for the AGM will also be available shortly on the
Company's website at
https://nanoporetech.com/about-us/investors/shareholder-information
(https://nanoporetech.com/about-us/investors/shareholder-information) .

 

 

-ENDS-

For further information please contact:

cosec@nanoporetech.com (mailto:cosec@nanoporetech.com)

ir@nanoporetech.com (mailto:ir@nanoporetech.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The company
has developed a new generation of nanopore-based sensing technology for
faster, information rich, accessible and affordable molecular analysis. The
first application is DNA/RNA sequencing, and the technology is in development
for the analysis of other types of molecules including proteins. The
technology is used in more than 125 countries to understand and characterise
the biology of humans and diseases such as cancer, plants, animals, bacteria,
viruses, and whole environments. Oxford Nanopore Technologies products are
intended for molecular biology applications and are not intended for
diagnostic purposes. For more information, please
visit: https://nanoporetech.com/ (https://nanoporetech.com/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSDFFLEISELM